Héloïse Torchin1, Pierre-Yves Ancel2, François Goffinet3, Jean-Michel Hascoët4, Patrick Truffert5, Diep Tran6, Cécile Lebeaux6, Pierre-Henri Jarreau7. 1. INSERM U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Center, Obstetrical, Perinatal and Pediatric Epidemiology Team, Paris, France; DHU Risk in Pregnancy, Cochin Hotel-Dieu Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; heloise.torchin@inserm.fr. 2. INSERM U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Center, Obstetrical, Perinatal and Pediatric Epidemiology Team, Paris, France; DHU Risk in Pregnancy, Cochin Hotel-Dieu Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Paris Descartes University, Paris, France; Unité de Recherche Clinique - Centre d' Investigation Clinique; 3. INSERM U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Center, Obstetrical, Perinatal and Pediatric Epidemiology Team, Paris, France; DHU Risk in Pregnancy, Cochin Hotel-Dieu Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Paris Descartes University, Paris, France; Maternité Port-Royal, and. 4. Maternite Regionale Universitaire, Neonatology, Nancy, France; and. 5. Jeanne de Flandre Hospital, Department of Neonatology CHRU de Lille, Lille Cedex, France. 6. INSERM U1153, Epidemiology and Statistics Sorbonne Paris Cité Research Center, Obstetrical, Perinatal and Pediatric Epidemiology Team, Paris, France; 7. DHU Risk in Pregnancy, Cochin Hotel-Dieu Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Paris Descartes University, Paris, France; Service de Médecine et Réanimation Néonatales de Port-Royal, Assistance Publique, Hôpitaux de Paris, Hôpital Cochin, Paris, France;
Abstract
OBJECTIVE: To investigate the relationship between placenta-mediated pregnancy complications and bronchopulmonary dysplasia (BPD) in very preterm infants. METHODS: National prospective population-based cohort study including 2697 singletons born before 32 weeks' gestation. The main outcome measure was moderate to severe BPD. Three groups of placenta-mediated pregnancy complications were compared with no placenta-mediated complications: maternal disorders only (gestational hypertension or preeclampsia), fetal disorders only (antenatal growth restriction), and both maternal and fetal disorders. RESULTS: Moderate to severe BPD rates were 8% in infants from pregnancies with maternal disorders, 15% from both maternal and fetal disorders, 23% from fetal disorders only, and 9% in the control group (P < .001). When we adjusted for gestational age, the risk of moderate to severe BPD was greater in the groups with fetal disorders only (odds ratio [OR] = 6.6; 95% confidence interval [CI], 4.1-10.7), with maternal and fetal disorders (OR = 3.7; 95% CI, 2.5-5.5), and with maternal disorders only (OR = 1.7; 95% CI, 1.0-2.7) than in the control group. When we also controlled for birth weight, the relationship remained in groups with fetal disorders only (OR = 4.2; 95% CI, 2.1-8.6) and with maternal and fetal disorders (OR = 2.1; 95% CI, 1.1-3.9). CONCLUSIONS: Placenta-mediated pregnancy complications with fetal consequences are associated with moderate to severe BPD in very preterm infants independently of gestational age and birth weight, but isolated maternal hypertensive disorders are not. Fetal growth restriction, more than birth weight, could predispose to impaired lung development.
OBJECTIVE: To investigate the relationship between placenta-mediated pregnancy complications and bronchopulmonary dysplasia (BPD) in very preterm infants. METHODS: National prospective population-based cohort study including 2697 singletons born before 32 weeks' gestation. The main outcome measure was moderate to severe BPD. Three groups of placenta-mediated pregnancy complications were compared with no placenta-mediated complications: maternal disorders only (gestational hypertension or preeclampsia), fetal disorders only (antenatal growth restriction), and both maternal and fetal disorders. RESULTS: Moderate to severe BPD rates were 8% in infants from pregnancies with maternal disorders, 15% from both maternal and fetal disorders, 23% from fetal disorders only, and 9% in the control group (P < .001). When we adjusted for gestational age, the risk of moderate to severe BPD was greater in the groups with fetal disorders only (odds ratio [OR] = 6.6; 95% confidence interval [CI], 4.1-10.7), with maternal and fetal disorders (OR = 3.7; 95% CI, 2.5-5.5), and with maternal disorders only (OR = 1.7; 95% CI, 1.0-2.7) than in the control group. When we also controlled for birth weight, the relationship remained in groups with fetal disorders only (OR = 4.2; 95% CI, 2.1-8.6) and with maternal and fetal disorders (OR = 2.1; 95% CI, 1.1-3.9). CONCLUSIONS: Placenta-mediated pregnancy complications with fetal consequences are associated with moderate to severe BPD in very preterm infants independently of gestational age and birth weight, but isolated maternal hypertensive disorders are not. Fetal growth restriction, more than birth weight, could predispose to impaired lung development.
Authors: Ludwig Gortner; Björn Misselwitz; David Milligan; Jennifer Zeitlin; Louis Kollée; Klaus Boerch; Rocco Agostino; Patrick Van Reempts; Jean-Louis Chabernaud; Gérard Bréart; Emile Papiernik; Pierre-Henri Jarreau; Manuel Carrapato; Janusz Gadzinowski; Elizabeth Draper Journal: Neonatology Date: 2010-08-23 Impact factor: 4.035
Authors: D J Henderson-Smart; J L Hutchinson; D A Donoghue; N J Evans; J M Simpson; I Wright Journal: Arch Dis Child Fetal Neonatal Ed Date: 2005-08-30 Impact factor: 5.747
Authors: Margreet J Teune; Aleid G van Wassenaer; Stef van Buuren; Ben Willem J Mol; Brent C Opmeer Journal: Eur J Obstet Gynecol Reprod Biol Date: 2012-05-11 Impact factor: 2.435
Authors: M Jakkula; T D Le Cras; S Gebb; K P Hirth; R M Tuder; N F Voelkel; S H Abman Journal: Am J Physiol Lung Cell Mol Physiol Date: 2000-09 Impact factor: 5.464
Authors: J Morales-Roselló; A Khalil; M Morlando; A Papageorghiou; A Bhide; B Thilaganathan Journal: Ultrasound Obstet Gynecol Date: 2014-03 Impact factor: 7.299
Authors: Michele Arigliani; Chiara Stocco; Elena Valentini; Carlo De Pieri; Luigi Castriotta; Maria Elena Ferrari; Cristina Canciani; Lorenza Driul; Maria Orsaria; Luigi Cattarossi; Paola Cogo Journal: Pediatr Res Date: 2021-01-19 Impact factor: 3.756
Authors: Gema E González-Luis; Elke van Westering-Kroon; Eduardo Villamor-Martinez; Maurice J Huizing; Mohammed A Kilani; Boris W Kramer; Eduardo Villamor Journal: Front Pediatr Date: 2020-04-28 Impact factor: 3.418
Authors: Jelonia T Rumph; Kayla J Rayford; Victoria R Stephens; Sharareh Ameli; Pius N Nde; Kevin G Osteen; Kaylon L Bruner-Tran Journal: Toxics Date: 2021-12-27